Deirdre K Tobias1,2, Jennifer J Stuart3,4, Shanshan Li5, Jorge Chavarro2,3,6, Eric B Rimm2,3,6, Janet Rich-Edwards3,4, Frank B Hu2,3,6, JoAnn E Manson1,3,4, Cuilin Zhang5,7. 1. Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. 2. Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. 3. Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. 4. Connors Center for Women's Health and Gender Biology, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. 5. Boston University School of Medicine, Boston, Massachusetts. 6. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. 7. Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Rockville, Maryland.
Abstract
Importance: Previous studies identify gestational diabetes (GD) as a risk factor for intermediate markers of cardiovascular disease (CVD) risk; however, few are prospective, evaluate hard CVD end points, or account for shared risk factors including body weight and lifestyle. Objective: To prospectively evaluate history of GD in relation to incident CVD risk. Design, Setting, and Participants: The Nurses' Health Study II (NHS II) is an observational cohort study of US female nurses established in 1989, with ongoing follow-up. Biennial questionnaires updated behavioral characteristics, health outcomes, and lifestyle factors. Multivariable Cox models estimated the hazard ratio (HR) and 95% CI for CVD risk. We included 89 479 women who reported at least 1 pregnancy and were free of CVD and cancer at baseline. Follow-up through May 31, 2015, was complete for more than 90% of eligible participants. Exposures: History of GD was self-reported at baseline (1989) via questionnaire and updated every 2 years. Main Outcomes and Measures: We observed 1161 incident self-reported nonfatal or fatal myocardial infarction or stroke, confirmed via medical records. Results: Participants had a mean (SD) age of 34.9 (4.7) years. Adjusting for age, prepregnancy body mass index, and other covariates, GD vs no GD was associated with subsequent CVD (HR, 1.43; 95% CI, 1.12-1.81). Additional adjustment for weight gain since pregnancy and updated lifestyle factors attenuated the association (HR, 1.29; 95% CI, 1.01-1.65). Classifying GD by progression to T2D in relation to CVD risk indicated a positive association for GD with progression to T2D vs no GD or T2D (HR, 4.02; 95% CI, 1.94-8.31), and an attenuated relationship for GD only (HR, 1.30; 95% CI, 0.99-1.71). Conclusions and Relevance: Gestational diabetes was positively associated with CVD later in life, although the absolute rate of CVD in this younger cohort of predominantly white women was low. This relationship is possibly mediated in part by subsequent weight gain and lack of healthy lifestyle.
Importance: Previous studies identify gestational diabetes (GD) as a risk factor for intermediate markers of cardiovascular disease (CVD) risk; however, few are prospective, evaluate hard CVD end points, or account for shared risk factors including body weight and lifestyle. Objective: To prospectively evaluate history of GD in relation to incident CVD risk. Design, Setting, and Participants: The Nurses' Health Study II (NHS II) is an observational cohort study of US female nurses established in 1989, with ongoing follow-up. Biennial questionnaires updated behavioral characteristics, health outcomes, and lifestyle factors. Multivariable Cox models estimated the hazard ratio (HR) and 95% CI for CVD risk. We included 89 479 women who reported at least 1 pregnancy and were free of CVD and cancer at baseline. Follow-up through May 31, 2015, was complete for more than 90% of eligible participants. Exposures: History of GD was self-reported at baseline (1989) via questionnaire and updated every 2 years. Main Outcomes and Measures: We observed 1161 incident self-reported nonfatal or fatal myocardial infarction or stroke, confirmed via medical records. Results:Participants had a mean (SD) age of 34.9 (4.7) years. Adjusting for age, prepregnancy body mass index, and other covariates, GD vs no GD was associated with subsequent CVD (HR, 1.43; 95% CI, 1.12-1.81). Additional adjustment for weight gain since pregnancy and updated lifestyle factors attenuated the association (HR, 1.29; 95% CI, 1.01-1.65). Classifying GD by progression to T2D in relation to CVD risk indicated a positive association for GD with progression to T2D vs no GD or T2D (HR, 4.02; 95% CI, 1.94-8.31), and an attenuated relationship for GD only (HR, 1.30; 95% CI, 0.99-1.71). Conclusions and Relevance: Gestational diabetes was positively associated with CVD later in life, although the absolute rate of CVD in this younger cohort of predominantly white women was low. This relationship is possibly mediated in part by subsequent weight gain and lack of healthy lifestyle.
Authors: Michael M Hannemann; William G Liddell; Angela C Shore; Penny M Clark; Jhon E Tooke Journal: J Vasc Res Date: 2002 Jul-Aug Impact factor: 1.934
Authors: Ying Bao; Monica L Bertoia; Elizabeth B Lenart; Meir J Stampfer; Walter C Willett; Frank E Speizer; Jorge E Chavarro Journal: Am J Public Health Date: 2016-07-26 Impact factor: 9.308
Authors: Alexandra P Oliveira; Iracema M P Calderon; Roberto A A Costa; Meliza G Roscani; Claudia G Magalhães; Vera T M Borges Journal: Diab Vasc Dis Res Date: 2015-03-12 Impact factor: 3.291
Authors: Duke Appiah; Pamela J Schreiner; Erica P Gunderson; Suma H Konety; David R Jacobs; Chike C Nwabuo; Imo A Ebong; Hilary K Whitham; David C Goff; Joao A Lima; Ivy A Ku; Samuel S Gidding Journal: Diabetes Care Date: 2016-01-06 Impact factor: 17.152
Authors: D K Tobias; C Zhang; J Chavarro; S Olsen; W Bao; A A Bjerregaard; T T Fung; J E Manson; F B Hu Journal: Int J Obes (Lond) Date: 2016-08-29 Impact factor: 5.095
Authors: Stefanie N Hinkle; Shristi Rawal; Anne Ahrendt Bjerregaard; Thor I Halldorsson; Mengying Li; Sylvia H Ley; Jing Wu; Yeyi Zhu; Liwei Chen; Aiyi Liu; Louise Groth Grunnet; Mohammad L Rahman; Freja Bach Kampmann; James L Mills; Sjurdur F Olsen; Cuilin Zhang Journal: Am J Clin Nutr Date: 2019-07-01 Impact factor: 7.045
Authors: Saifur R Khan; Haneesha Mohan; Ying Liu; Battsetseg Batchuluun; Himaben Gohil; Dana Al Rijjal; Yousef Manialawy; Brian J Cox; Erica P Gunderson; Michael B Wheeler Journal: Diabetologia Date: 2019-01-15 Impact factor: 10.122
Authors: Yamnia I Cortés; Janet M Catov; Maria Brooks; Samar R El Khoudary; Rebecca C Thurston; Karen A Matthews; Carmen R Isasi; Elizabeth A Jackson; Emma Barinas-Mitchell Journal: Atherosclerosis Date: 2019-07-30 Impact factor: 5.162